Form 4: Acrivon Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Mary Miller, Chief Legal Officer of Acrivon Therapeutics, Inc., sold 573 shares of common stock on July 21, 2026 for $1.76 per share.
Summary
- Open-market sale: disposed of 573 Common Stock at $1.76 ($1,008) on July 21, 2026; holds 82,194 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,008 of stock on the open market.
Insider Transactions
Mary Miller — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-21 | Open-market sale | Common Stock | 573 | $2 | $1.0K | 82,194 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-21 | Open-market sale (573 shares) |
Keywords
insider transaction, Form 4, ACRV, Acrivon Therapeutics, Inc., bearish, Mary Miller
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.